共 27 条
[1]
Lackofclopidogrel CYP3A4statininteractioninpatientswithacutecoronarysyndrome. MukherjeeD,Kline RogersE,FangJ,etal. Heart . 2005
[2]
Patientswithelevatedliver enzymesarenotathigherriskforstatinhepatoxicity. ChalasaniN,AljadheyH,KestersonJ,etal. Gastroenterology . 2004
[3]
FDAadverseeventreportsonstatin associated rhabdomyolysis. OmarMA,WilsonJP. AnnPharmacother . 2002
[4]
Statin associatedmyopathy. Hamilton GraigI. MedJAust . 2001
[5]
Fatalliverfailurewithatorvasta tin. PergerL,KohlerM,FattingerK,etal. Journal of Hepatology . 2003
[6]
Newinsightsintothepharmacody namicsandpharmacokineticpropertiesofstatins. CorsiniA,BellostaS,BaettaR,etal. PharmacolTherap . 1999
[7]
Safetyandtolerabilityofpravastatinin long termclinicaltrials:prospectivePravastatinPooling(PPP)Project. PfefferMA,KeechA,SacksFM. Circulation . 2002
[8]
Atherosclerosis[P]. DONG CHUNMING;GOLDSCHMIDT PASCAL J.中国专利:US2008095751A1,2008-04-24
[9]
Nonalcoholicfattyliverdisease:the mostcommoncauseofabnormalliverenzymesintheUSpopulation. ClarkJM,BrancatiFL,DiehlAM. Gastroenterology . 2001
[10]
Istherevalueinliverfunctiontestandcreatinephos phokinasemonitoringwithstatinuse. SnidermanAD. The American Journal of Cardiology . 2004